Newer evidence has suggested, however, that gabapentin may not work for all pain conditions and is associated with falls. As ...

More than 233,000 bottles of duloxetine capsules sold by Rising Pharmaceuticals were voluntarily recalled on Nov. 19, and the U.S. Food and Drug Administration assigned the recall as a class II ...

An antidepressant medication named duloxetine has been recalled by the U.S. Food and Drug Administration (FDA) due to the presence of carcinogenic chemicals. The drug was voluntarily recalled by a ...

For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages of up to 120 mg daily have been studied. [25] Higher dosages do not have proven benefit and may ...

The U.S. Food and Drug Administration classified capsules of duloxetine, sold by New Jersey-based company Rising Pharmaceuticals, as a Class II risk on Dec. 5. The risk level is the FDA's second ...

A recent Food and Drug Administration (FDA) recall of a commonly prescribed antidepressant, Duloxetine, because it may contain a potentially cancer-causing agent that could impact the health of ...

FDA recalls over 200,000 duloxetine bottles due to N-nitroso-duloxetine contamination, increasing cancer risk.

bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.

The prescription drug Cymbalta, generically duloxetine, is under recall for cancer-causing impurities that may have occurred naturally.

dosage and administration, cost, and place in therapy of duloxetine for major depression, pain from diabetic peripheral neuropathy, and stress urinary incontinence are reviewed. Summary ...